Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3963331 | Journal of Obstetrics and Gynaecology Canada | 2015 | 13 Pages |
Abstract
Umbilical cord blood is a readily available source of hematopoetic stem cells used with increasing frequency as an alternative to bone marrow or peripheral stem cell transplantation to treat malignant and non-malignant conditions in children and adults There is minimal harm to the mother or newborn provided that priority is given to maternal/newborn safety during childbirth management. Recipients of umbilical cord stem cells may experience graft-versus-host disease, transfer of infection or genetic abnormalities, or therapeutic failure The financial burden on the health system for public cord blood banking and on families for private cord blood banking is considerable.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
B. Anthony MD, David S. MD, Robert F. MD,